Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFκB, cyclinD and MMP-1 transcription

Keyphrases

• Cell Proliferation 100%
• Cyclin D 100%
• Curcumin 100%
• Breast Cancer Cells 100%
• MDA-MB-231 100%
• Matrix metalloproteinase-1 (MMP-1) 100%
• Cell-mediated 100%
• Cyclin-dependent Kinase 4 (CDK4) 20%
• Cell Cycle Proteins 20%
• Cyclin D1 (CCND1) 20%
• Immunochemistry 20%
• Cell Inhibition 20%
• Water-soluble 10%
• Dose Effect 10%
• Treatment Group 10%
• Western Blot 10%
• Quantitative PCR 10%
• Inhibitory Effect 10%
• Antitumor Activity 10%
• Apoptosis Induction 10%
• MRNA Expression 10%
• Tumor 10%
• Active Constituents 10%
• Tetrazolium 10%
• MDA-MB-231 Cancer Cells 10%
• Matrix Metalloproteinases 10%
• Breast Cancer Cell Lines 10%
• Antiproliferation 10%
• Inhibition Activity 10%
• Cell Proliferation Assay 10%
• WST-1 10%
• WST-1 Assay 10%

Biochemistry, Genetics and Molecular Biology

• Transcription 100%
• Cell Proliferation 100%
• Cancer Cell 100%
• Downregulation 100%
• Interstitial Collagenase 100%
• Cyclin D1 40%
• Cell Cycle Protein 40%
• Messenger RNA 20%
• Western Blot 20%
• Programmed Cell Death 20%
• Antineoplastic Activity 20%
• Reverse Transcription Polymerase Chain Reaction 20%
• P21 20%
• Matrix Metalloproteinase 20%
• Turmeric 20%

Immunology and Microbiology

• Downregulation 100%
• Cancer Cell 100%
• Cell Proliferation 100%
• Cell Cycle 50%
• Breast Cancer Cell Line 50%
• Cyclin D1 50%
• Immunochemistry 50%
• Programmed Cell Death 25%
• Western Blot 25%
• Antineoplastic Activity 25%
• Reverse Transcription Polymerase Chain Reaction 25%